Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 65,100 | 236,700 | 173,600 | 122,000 | 63,900 |
| Depreciation Amortization | 13,800 | 58,000 | 43,200 | 29,300 | 14,500 |
| Income taxes - deferred | 1,700 | -600 | 2,200 | 1,800 | 1,500 |
| Accounts receivable | -24,900 | -53,700 | -38,500 | -48,300 | -34,900 |
| Other Working Capital | -81,400 | -36,000 | -29,400 | -59,800 | -53,000 |
| Other Operating Activity | -5,000 | 103,800 | 63,700 | 54,400 | 22,900 |
| Operating Cash Flow | $-30,700 | $308,200 | $214,800 | $99,400 | $14,900 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 84,200 | -290,300 | -213,500 | -286,400 | -106,300 |
| PPE Investments | -18,000 | -72,700 | -46,700 | -31,100 | -13,900 |
| Net Acquisitions | N/A | -42,600 | -42,600 | -38,700 | -42,600 |
| Purchase Of Investment | 2,200 | -2,300 | 6,900 | 0 | 5,000 |
| Sale Of Investment | N/A | 9,100 | N/A | 4,900 | N/A |
| Purchase Sale Intangibles | N/A | -7,700 | -2,300 | -2,300 | -300 |
| Other Investing Activity | 0 | -7,700 | -2,300 | -2,200 | -300 |
| Investing Cash Flow | $68,400 | $-406,500 | $-298,200 | $-353,500 | $-158,100 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 151,600 | 526,100 | 505,500 | 200,500 | 110,500 |
| Debt Repayment | -120,500 | -421,700 | -376,700 | -71,300 | -5,200 |
| Common Stock Issued | 24,900 | 59,500 | 48,600 | 33,400 | 13,200 |
| Common Stock Repurchased | -89,500 | -303,400 | -263,300 | -159,000 | -75,800 |
| Other Financing Activity | 30,400 | 4,300 | 4,300 | 12,000 | 16,800 |
| Financing Cash Flow | $-3,100 | $-135,200 | $-81,600 | $15,600 | $59,500 |
| Exchange Rate Effect | 7,500 | 8,600 | 12,900 | 18,000 | 12,800 |
| Beginning Cash Position | 171,200 | 396,100 | 396,100 | 396,100 | 396,100 |
| End Cash Position | 213,300 | 171,200 | 244,000 | 175,600 | 325,200 |
| Net Cash Flow | $42,100 | $-224,900 | $-152,100 | $-220,500 | $-70,900 |
| Free Cash Flow | |||||
| Operating Cash Flow | -30,700 | 308,200 | 214,800 | 99,400 | 14,900 |
| Capital Expenditure | -18,000 | -76,600 | -50,600 | -31,100 | -13,900 |
| Free Cash Flow | -48,700 | 231,600 | 164,200 | 68,300 | 1,000 |